Want to see AKTS full AI Analyst Report?
ETFs with Aktis Oncology, Inc. (AKTS) Exposure
The following ETFs maintain exposure to Aktis Oncology, Inc. (AKTS). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
34 ETFs Hold Aktis Oncology, Inc. (AKTS)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in AKTS |
|---|---|---|---|---|---|---|
| YALL | God Bless America ETF | $79.03M | 0.65% | 1.32% | $1.04M | 0.12% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.56% | $194.09K | 0.02% |
| TMED | T. Rowe Price Health Care ETF | $34.83M | 0.44% | 0.31% | $107.71K | 0.01% |
| TSEE | T. Rowe Price Small Cap ETF | $10.71M | 0.59% | 0.20% | $21.82K | <0.01% |
| XBI | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | 0.08% | $8.98M | 0.99% |
| TNXT | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | 0.05% | $10.45K | <0.01% |
| VTWG | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | 0.02% | $417.75K | 0.04% |
| IWO | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | 0.02% | $2.94M | 0.34% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | $270.82M | 0.39% | 0.02% | $52.04K | <0.01% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | 0.02% | $2,647.92 | <0.01% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | 0.02% | $3.23M | 0.31% |
| RESM | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | 0.02% | $1,027.85 | <0.01% |
| PWS | Pacer WealthShield ETF | $14.55M | 0.60% | 0.02% | $2,460.1 | <0.01% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | 0.02% | $51.22K | <0.01% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | 0.02% | $185.35 | <0.01% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | 0.02% | $232.72K | 0.03% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | 0.02% | $12.03M | 1.33% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | 0.01% | $27.20K | <0.01% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | 0.01% | $671.71K | 0.07% |
| VTWV | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | 0.01% | $160.88K | 0.02% |
| SCHA | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | 0.01% | $2.27M | 0.25% |
| IWN | iShares Russell 2000 Value ETF | $14.23B | 0.24% | <0.01% | $1.37M | 0.15% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $5.71M | 0.55% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $589.75 | <0.01% |
| CAUS | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | <0.01% | $14.15K | <0.01% |
| AVGC | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | <0.01% | $18.42K | <0.01% |
| AVUS | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | <0.01% | $18.42K | <0.01% |
| AVUS | Avantis U.S. Equity ETF | $14.88B | 0.15% | <0.01% | $187.57K | 0.02% |
| IWV | iShares Russell 3000 ETF | $20.56B | 0.20% | <0.01% | $162.89K | 0.02% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $50.47K | <0.01% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $16.62M | 1.59% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | <0.01% | $579.29K | 0.06% |
| SCHB | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | <0.01% | $234.48K | 0.03% |
| AVSU | Avantis Responsible U.S. Equity ETF | $487.62M | 0.15% | <0.01% | $1,516.5 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in AKTS |
|---|---|---|---|---|---|---|
| YALL | 1.32% | God Bless America ETF | $79.03M | 0.65% | $1.04M | 0.12% |
| BBC | 0.56% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $194.09K | 0.02% |
| TMED | 0.31% | T. Rowe Price Health Care ETF | $34.83M | 0.44% | $107.71K | 0.01% |
| TSEE | 0.20% | T. Rowe Price Small Cap ETF | $10.71M | 0.59% | $21.82K | <0.01% |
| XBI | 0.08% | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | $8.98M | 0.99% |
| TNXT | 0.05% | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | $10.45K | <0.01% |
| VTWG | 0.02% | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | $417.75K | 0.04% |
| IWO | 0.02% | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | $2.94M | 0.34% |
| OMFS | 0.02% | Invesco Russell 2000 Dynamic Multifactor ETF | $270.82M | 0.39% | $52.04K | <0.01% |
| VRSD | 0.02% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $2,647.92 | <0.01% |
| VTWO | 0.02% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $3.23M | 0.31% |
| RESM | 0.02% | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | $1,027.85 | <0.01% |
| PWS | 0.02% | Pacer WealthShield ETF | $14.55M | 0.60% | $2,460.1 | <0.01% |
| RTYS | 0.02% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $51.22K | <0.01% |
| RB | 0.02% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $185.35 | <0.01% |
| RSSL | 0.02% | Global X Russell 2000 ETF | $1.47B | 0.08% | $232.72K | 0.03% |
| IWM | 0.02% | iShares Russell 2000 ETF | $76.76B | 0.19% | $12.03M | 1.33% |
| ITWO | 0.01% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $27.20K | <0.01% |
| R2EH | 0.01% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $671.71K | 0.07% |
| VTWV | 0.01% | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | $160.88K | 0.02% |
| SCHA | 0.01% | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | $2.27M | 0.25% |
| IWN | <0.01% | iShares Russell 2000 Value ETF | $14.23B | 0.24% | $1.37M | 0.15% |
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $5.71M | 0.55% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $589.75 | <0.01% |
| CAUS | <0.01% | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | $14.15K | <0.01% |
| AVGC | <0.01% | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | $18.42K | <0.01% |
| AVUS | <0.01% | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | $18.42K | <0.01% |
| AVUS | <0.01% | Avantis U.S. Equity ETF | $14.88B | 0.15% | $187.57K | 0.02% |
| IWV | <0.01% | iShares Russell 3000 ETF | $20.56B | 0.20% | $162.89K | 0.02% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $50.47K | <0.01% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $16.62M | 1.59% |
| ITOT | <0.01% | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | $579.29K | 0.06% |
| SCHB | <0.01% | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | $234.48K | 0.03% |
| AVSU | <0.01% | Avantis Responsible U.S. Equity ETF | $487.62M | 0.15% | $1,516.5 | <0.01% |
Popular ETF Comparisons
AKTS ETF Exposure FAQ
What ETFs hold Aktis Oncology, Inc. stock?
Aktis Oncology, Inc. (AKTS) is currently held by 34 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to AKTS include SPDR (XBI), iShares (IWO) and Truth Social (YALL).
Which ETF has the largest exposure to AKTS?
The ETF with the largest exposure to AKTS is SPDR (XBI), with approximately $8.98M in market value exposure.
How much AKTS stock is held by ETFs?
ETFs currently hold approximately $13.76M worth of Aktis Oncology, Inc. (AKTS) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.